BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 1300143 CC(C)(C)c1ncn(CC(=O)N2CCN(C[C@H]2CO)c2sc(nc2-c2cnc(nc2)C(F)(F)F)C(F)(F)F)n1 InChI=1S/C22H24F6N8O2S/c1-20(2,3)17-31-11-35(33-17)9-14(38)36-5-4-34(8-13(36)10-37)16-15(32-19(39-16)22(26,27)28)12-6-29-18(30-7-12)21(23,24)25/h6-7,11,13,37H,4-5,8-10H2,1-3H3 ZXSLRBPBMBEVPN-UHFFFAOYSA-N 610020 US10053457, Example 1::2-(3-tert-Butyl-[1,2,4]triazol-1-yl)-1-{(S)-2-hydroxymethyl-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-ethanone C-X-C chemokine receptor type 3 Homo sapiens 6.70 US Patent 10.7270/Q2S46X2G aid1919602 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610020 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610020&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485668 483620187 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300144 Cc1nc(C)n(CC(=O)N2CCN(C[C@H]2CO)c2sc(nc2-c2cnc(nc2)C(F)(F)F)C(F)(F)F)n1 InChI=1S/C20H20F6N8O2S/c1-10-29-11(2)34(31-10)8-14(36)33-4-3-32(7-13(33)9-35)16-15(30-18(37-16)20(24,25)26)12-5-27-17(28-6-12)19(21,22)23/h5-6,13,35H,3-4,7-9H2,1-2H3 UNBODQFVLQNKLE-UHFFFAOYSA-N 610021 US10053457, Example 2::2-(3,5-Dimethyl-[1,2,4]triazol-1-yl)-1-{(S)-2-hydroxymethyl-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-ethanone C-X-C chemokine receptor type 3 Homo sapiens 6.00 US Patent 10.7270/Q2S46X2G aid1919602 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610021 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610021&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485652 483620188 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300145 OC[C@@H]1CN(CCN1C(=O)Cn1cnc(n1)C1CC1)c1sc(nc1-c1cnc(nc1)C(F)(F)F)C(F)(F)F InChI=1S/C21H20F6N8O2S/c22-20(23,24)18-28-5-12(6-29-18)15-17(38-19(31-15)21(25,26)27)33-3-4-35(13(7-33)9-36)14(37)8-34-10-30-16(32-34)11-1-2-11/h5-6,10-11,13,36H,1-4,7-9H2 DAFKTUHZZXUBLN-UHFFFAOYSA-N 610068 US10053457, Example 3::2-(3-Cyclopropyl-[1,2,4]triazol-1-yl)-1-{(S)-2-hydroxymethyl-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-ethanone C-X-C chemokine receptor type 3 Homo sapiens 3.00 US Patent 10.7270/Q2S46X2G aid1919602 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610068 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610068&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485715 483620235 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300146 CC(C)c1ncn(CC(=O)N2CCN(C[C@H]2CO)c2sc(nc2-c2cnc(nc2)C(F)(F)F)C(F)(F)F)n1 InChI=1S/C21H22F6N8O2S/c1-11(2)16-30-10-34(32-16)8-14(37)35-4-3-33(7-13(35)9-36)17-15(31-19(38-17)21(25,26)27)12-5-28-18(29-6-12)20(22,23)24/h5-6,10-11,13,36H,3-4,7-9H2,1-2H3 BHWGZPATDOVSCG-UHFFFAOYSA-N 610138 US10053457, Example 4::1-{(S)-2-Hydroxymethyl-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-2-(3-isopropyl-[1,2,4]triazol-1-yl)-ethanone C-X-C chemokine receptor type 3 Homo sapiens 1.80 US Patent 10.7270/Q2S46X2G aid1919602 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610138 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610138&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485723 483620304 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300147 OC[C@@H]1CN(CCN1C(=O)Cn1cnc(n1)C(F)(F)F)c1sc(nc1-c1cnc(nc1)C(F)(F)F)C(F)(F)F InChI=1S/C19H15F9N8O2S/c20-17(21,22)14-29-3-9(4-30-14)12-13(39-16(32-12)19(26,27)28)34-1-2-36(10(5-34)7-37)11(38)6-35-8-31-15(33-35)18(23,24)25/h3-4,8,10,37H,1-2,5-7H2 LZBLSLKZLJWLQF-UHFFFAOYSA-N 610160 US10053457, Example 5::1-{(S)-2-Hydroxymethyl-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-2-(3-trifluoromethyl-[1,2,4]triazol-1-yl)-ethanone C-X-C chemokine receptor type 3 Homo sapiens 4.00 US Patent 10.7270/Q2S46X2G aid1919602 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610160 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610160&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485687 483620325 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300148 CCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](CO)C1)C(=O)Cn1cnc(n1)C(F)(F)F)C(F)(F)F InChI=1S/C20H20F6N8O3S/c1-2-37-18-27-5-11(6-28-18)14-15(38-17(30-14)20(24,25)26)32-3-4-34(12(7-32)9-35)13(36)8-33-10-29-16(31-33)19(21,22)23/h5-6,10,12,35H,2-4,7-9H2,1H3 KAZYZPSVWIJVCD-UHFFFAOYSA-N 610186 US10053457, Example 6::1-{(S)-4-[4-(2-Ethoxy-pyrimidin-5-yl)-2-trifluoromethyl-thiazol-5-yl]-2-hydroxymethyl-piperazin-1-yl}-2-(3-trifluoromethyl-[1,2,4]triazol-1-yl)-ethanone C-X-C chemokine receptor type 3 Homo sapiens 4.60 US Patent 10.7270/Q2S46X2G aid1919602 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610186 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610186&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485694 483620351 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300149 CCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](CO)C1)C(=O)Cn1nc(C)nc1C)C(F)(F)F InChI=1S/C21H25F3N8O3S/c1-4-35-20-25-7-14(8-26-20)17-18(36-19(28-17)21(22,23)24)30-5-6-31(15(9-30)11-33)16(34)10-32-13(3)27-12(2)29-32/h7-8,15,33H,4-6,9-11H2,1-3H3 KZIASVKYOSOUFZ-UHFFFAOYSA-N 610188 US10053457, Example 7::2-(3,5-Dimethyl-[1,2,4]triazol-1-yl)-1-{(S)-4-[4-(2-ethoxy-pyrimidin-5-yl)-2-trifluoromethyl-thiazol-5-yl]-2-hydroxymethyl-piperazin-1-yl}-ethanone C-X-C chemokine receptor type 3 Homo sapiens 3.10 US Patent 10.7270/Q2S46X2G aid1919602 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610188 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610188&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485681 483620353 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300150 Cc1nc(C)n(CC(=O)N2CCN(C[C@H]2CO)c2sc(nc2-c2cnc(nc2)C2CC2)C(F)(F)F)n1 InChI=1S/C22H25F3N8O2S/c1-12-28-13(2)33(30-12)10-17(35)32-6-5-31(9-16(32)11-34)20-18(29-21(36-20)22(23,24)25)15-7-26-19(27-8-15)14-3-4-14/h7-8,14,16,34H,3-6,9-11H2,1-2H3 ZGISBRGPKNASOI-UHFFFAOYSA-N 610196 US10053457, Example 8::1-{(S)-4-[4-(2-Cyclopropyl-pyrimidin-5-yl)-2-trifluoromethyl-thiazol-5-yl]-2-hydroxymethyl-piperazin-1-yl}-2-(3,5-di methyl-[1,2,4]triazol-1-yl)-ethanone C-X-C chemokine receptor type 3 Homo sapiens 10.00 US Patent 10.7270/Q2S46X2G aid1919602 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610196 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610196&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485637 483620361 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300151 OC[C@@H]1CN(CCN1C(=O)Cn1cnc(n1)C(F)(F)F)c1sc(nc1-c1cnc(nc1)C1CC1)C(F)(F)F InChI=1S/C21H20F6N8O2S/c22-20(23,24)18-30-10-34(32-18)8-14(37)35-4-3-33(7-13(35)9-36)17-15(31-19(38-17)21(25,26)27)12-5-28-16(29-6-12)11-1-2-11/h5-6,10-11,13,36H,1-4,7-9H2 DQFRAXJGMQALQK-UHFFFAOYSA-N 610381 US10053457, Example 9::1-{(S)-4-[4-(2-Cyclopropyl-pyrimidin-5-yl)-2-trifluoromethyl-thiazol-5-yl]-2-hydroxymethyl-piperazin-1-yl}-2-(3-trifluoromethyl-[1,2,4]triazol-1-yl)-ethanone C-X-C chemokine receptor type 3 Homo sapiens 1.30 US Patent 10.7270/Q2S46X2G aid1919602 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610381 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610381&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485711 483620546 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300152 CC(C)c1ncn(CC(=O)N2CCN(C[C@@H]2CO)c2sc(nc2-c2ccc(nc2)C(F)(F)F)C(F)(F)F)n1 InChI=1S/C22H23F6N7O2S/c1-12(2)18-30-11-34(32-18)9-16(37)35-6-5-33(8-14(35)10-36)19-17(31-20(38-19)22(26,27)28)13-3-4-15(29-7-13)21(23,24)25/h3-4,7,11-12,14,36H,5-6,8-10H2,1-2H3 QTGXTHMTKKQHMR-UHFFFAOYSA-N 610414 US10053457, Example 10::1-{(R)-2-Hydroxymethyl-4-[2-trifluoromethyl-4-(6-trifluoromethyl-pyridin-3-yl)-thiazol-5-yl]-piperazin-1-yl}-2-(3-isopropyl-[1,2,4]triazol-1-yl)-ethanone C-X-C chemokine receptor type 3 Homo sapiens 1.10 US Patent 10.7270/Q2S46X2G aid1919602 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610414 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610414&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485728 483620579 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300153 CC(C)c1ncn(CC(=O)N2CCN(C[C@@H]2CO)c2sc(nc2-c2cnc(nc2)C(F)(F)F)C(F)(F)F)n1 InChI=1S/C21H22F6N8O2S/c1-11(2)16-30-10-34(32-16)8-14(37)35-4-3-33(7-13(35)9-36)17-15(31-19(38-17)21(25,26)27)12-5-28-18(29-6-12)20(22,23)24/h5-6,10-11,13,36H,3-4,7-9H2,1-2H3 BHWGZPATDOVSCG-UHFFFAOYSA-N 610415 US10053457, Example 11::1-{(R)-2-Hydroxymethyl-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-2-(3-isopropyl-[1,2,4]triazol-1-yl)-ethanone C-X-C chemokine receptor type 3 Homo sapiens 3.40 US Patent 10.7270/Q2S46X2G aid1919602 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610415 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610415&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485695 483620580 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300154 Cc1nc(C)n(CC(=O)N2CCN(C[C@@H]2CO)c2sc(nc2-c2cnc(nc2)C(F)(F)F)C(F)(F)F)n1 InChI=1S/C20H20F6N8O2S/c1-10-29-11(2)34(31-10)8-14(36)33-4-3-32(7-13(33)9-35)16-15(30-18(37-16)20(24,25)26)12-5-27-17(28-6-12)19(21,22)23/h5-6,13,35H,3-4,7-9H2,1-2H3 UNBODQFVLQNKLE-UHFFFAOYSA-N 610416 US10053457, Example 12::2-(3,5-Dimethyl-[1,2,4]triazol-1-yl)-1-{(R)-2-hydroxymethyl-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-ethanone C-X-C chemokine receptor type 3 Homo sapiens 6.90 US Patent 10.7270/Q2S46X2G aid1919602 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610416 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610416&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485710 483620581 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300155 OC[C@H]1CN(CCN1C(=O)Cn1cnc2ccccc12)c1sc(nc1-c1cnc(nc1)C(F)(F)F)C(F)(F)F InChI=1S/C23H19F6N7O2S/c24-22(25,26)20-30-7-13(8-31-20)18-19(39-21(33-18)23(27,28)29)34-5-6-36(14(9-34)11-37)17(38)10-35-12-32-15-3-1-2-4-16(15)35/h1-4,7-8,12,14,37H,5-6,9-11H2 WFYDWTNVQOVKAZ-UHFFFAOYSA-N 610417 US10053457, Example 13::2-Benzoimidazol-1-yl-1-{(R)-2-hydroxymethyl-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-ethanone C-X-C chemokine receptor type 3 Homo sapiens 1.20 US Patent 10.7270/Q2S46X2G aid1919602 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610417 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610417&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485719 483620582 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300156 OC[C@H]1CN(CCN1C(=O)Cn1ccc2cc(F)ccc12)c1sc(nc1-c1cnc(nc1)C(F)(F)F)C(F)(F)F InChI=1S/C24H19F7N6O2S/c25-15-1-2-17-13(7-15)3-4-35(17)11-18(39)37-6-5-36(10-16(37)12-38)20-19(34-22(40-20)24(29,30)31)14-8-32-21(33-9-14)23(26,27)28/h1-4,7-9,16,38H,5-6,10-12H2 LQRHNGOTLMNBKG-UHFFFAOYSA-N 610418 US10053457, Example 14::2-(5-Fluoro-indol-1-yl)-1-{(R)-2-hydroxymethyl-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-ethanone C-X-C chemokine receptor type 3 Homo sapiens 0.700 US Patent 10.7270/Q2S46X2G aid1919602 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610418 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610418&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485664 483620583 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300157 COc1ccc2n(CC(=O)N3CCN(C[C@@H]3CO)c3sc(nc3-c3cnc(nc3)C(F)(F)F)C(F)(F)F)ccc2c1 InChI=1S/C25H22F6N6O3S/c1-40-17-2-3-18-14(8-17)4-5-35(18)12-19(39)37-7-6-36(11-16(37)13-38)21-20(34-23(41-21)25(29,30)31)15-9-32-22(33-10-15)24(26,27)28/h2-5,8-10,16,38H,6-7,11-13H2,1H3 USNOADPXDZVWHO-UHFFFAOYSA-N 610419 US10053457, Example 15::1-{(R)-2-Hydroxymethyl-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-2-(5-methoxy-indol-1-yl)-ethanone C-X-C chemokine receptor type 3 Homo sapiens 2.30 US Patent 10.7270/Q2S46X2G aid1919602 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610419 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610419&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485725 483620584 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300158 Cc1ncn(CC(=O)N2CCN(C[C@@H]2CO)c2sc(nc2-c2cnc(nc2)C(F)(F)F)C(F)(F)F)n1 InChI=1S/C19H18F6N8O2S/c1-10-28-9-32(30-10)7-13(35)33-3-2-31(6-12(33)8-34)15-14(29-17(36-15)19(23,24)25)11-4-26-16(27-5-11)18(20,21)22/h4-5,9,12,34H,2-3,6-8H2,1H3 YZWIMDHUANZMQA-UHFFFAOYSA-N 610420 US10053457, Example 16::1-{(R)-2-Hydroxymethyl-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-2-(3-methyl-[1,2,4]triazol-1-yl)-ethanone C-X-C chemokine receptor type 3 Homo sapiens 3.90 US Patent 10.7270/Q2S46X2G aid1919602 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610420 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610420&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485714 483620585 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300159 COCc1ncn(CC(=O)N2CCN(C[C@@H]2CO)c2sc(nc2-c2cnc(nc2)C(F)(F)F)C(F)(F)F)n1 InChI=1S/C20H20F6N8O3S/c1-37-9-13-29-10-33(31-13)7-14(36)34-3-2-32(6-12(34)8-35)16-15(30-18(38-16)20(24,25)26)11-4-27-17(28-5-11)19(21,22)23/h4-5,10,12,35H,2-3,6-9H2,1H3 RJEBPSVBZFRUQD-UHFFFAOYSA-N 610421 US10053457, Example 17::1-{(R)-2-Hydroxymethyl-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-2-(3-methoxymethyl-[1,2,4]triazol-1-yl)-ethanone C-X-C chemokine receptor type 3 Homo sapiens 5.90 US Patent 10.7270/Q2S46X2G aid1919602 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610421 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610421&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 135373609 483620586 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300160 Cc1nc(no1)-c1ncn(CC(=O)N2CCN(C[C@@H]2CO)c2sc(nc2-c2cnc(nc2)C(F)(F)F)C(F)(F)F)n1 InChI=1S/C21H18F6N10O3S/c1-10-31-16(34-40-10)15-30-9-36(33-15)7-13(39)37-3-2-35(6-12(37)8-38)17-14(32-19(41-17)21(25,26)27)11-4-28-18(29-5-11)20(22,23)24/h4-5,9,12,38H,2-3,6-8H2,1H3 QYOBFBGMFZFQAQ-UHFFFAOYSA-N 610422 US10053457, Example 18::1-{(R)-2-Hydroxymethyl-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-2-[3-(5-methyl-[1,2,4]oxadiazol-3-yl)-[1,2,4]triazol-1-yl]-ethanone C-X-C chemokine receptor type 3 Homo sapiens 510 US Patent 10.7270/Q2S46X2G aid1919602 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610422 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610422&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485743 483620587 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300161 OC[C@H]1CN(CCN1C(=O)Cn1cnc(n1)-c1ccccc1)c1sc(nc1-c1cnc(nc1)C(F)(F)F)C(F)(F)F InChI=1S/C24H20F6N8O2S/c25-23(26,27)21-31-8-15(9-32-21)18-20(41-22(34-18)24(28,29)30)36-6-7-38(16(10-36)12-39)17(40)11-37-13-33-19(35-37)14-4-2-1-3-5-14/h1-5,8-9,13,16,39H,6-7,10-12H2 HSXNORDTRMEGJR-UHFFFAOYSA-N 610423 US10053457, Example 19::1-{(R)-2-Hydroxymethyl-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-2-(3-phenyl-[1,2,4]triazol-1-yl)-ethanone C-X-C chemokine receptor type 3 Homo sapiens 42.0 US Patent 10.7270/Q2S46X2G aid1919602 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610423 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610423&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485702 483620588 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300162 CC(=O)c1ncn(CC(=O)N2CCN(C[C@@H]2CO)c2sc(nc2-c2cnc(nc2)C(F)(F)F)C(F)(F)F)n1 InChI=1S/C20H18F6N8O3S/c1-10(36)15-29-9-33(31-15)7-13(37)34-3-2-32(6-12(34)8-35)16-14(30-18(38-16)20(24,25)26)11-4-27-17(28-5-11)19(21,22)23/h4-5,9,12,35H,2-3,6-8H2,1H3 DWFGJTJGAFWCDN-UHFFFAOYSA-N 610424 US10053457, Example 20::2-(3-Acetyl-[1,2,4]triazol-1-yl)-1-{(R)-2-hydroxymethyl-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-ethanone C-X-C chemokine receptor type 3 Homo sapiens 6.40 US Patent 10.7270/Q2S46X2G aid1919602 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610424 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610424&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485663 483620589 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300163 CC(O)c1ncn(CC(=O)N2CCN(C[C@@H]2CO)c2sc(nc2-c2cnc(nc2)C(F)(F)F)C(F)(F)F)n1 InChI=1S/C20H20F6N8O3S/c1-10(36)15-29-9-33(31-15)7-13(37)34-3-2-32(6-12(34)8-35)16-14(30-18(38-16)20(24,25)26)11-4-27-17(28-5-11)19(21,22)23/h4-5,9-10,12,35-36H,2-3,6-8H2,1H3 GLRPZUMNSOSOFU-UHFFFAOYSA-N 610425 US10053457, Example 21::2-[3-(1-Hydroxy-ethyl)-[1,2,4]triazol-1-yl]-1-{(R)-2-hydroxymethyl-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-ethanone C-X-C chemokine receptor type 3 Homo sapiens 4.30 US Patent 10.7270/Q2S46X2G aid1919602 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610425 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610425&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485675 483620590 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300164 Cc1ccn(CC(=O)N2CCN(C[C@@H]2CO)c2sc(nc2-c2cnc(nc2)C(F)(F)F)C(F)(F)F)n1 InChI=1S/C20H19F6N7O2S/c1-11-2-3-32(30-11)9-14(35)33-5-4-31(8-13(33)10-34)16-15(29-18(36-16)20(24,25)26)12-6-27-17(28-7-12)19(21,22)23/h2-3,6-7,13,34H,4-5,8-10H2,1H3 GQQMDOGXIJRPDK-UHFFFAOYSA-N 610426 US10053457, Example 22::1-{(R)-2-Hydroxymethyl-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-2-(3-methyl-pyrazol-1-yl)-ethanone C-X-C chemokine receptor type 3 Homo sapiens 1.60 US Patent 10.7270/Q2S46X2G aid1919602 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610426 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610426&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485632 483620591 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300165 OC[C@H]1CN(CCN1C(=O)Cn1cnc(n1)-c1ccccn1)c1sc(nc1-c1cnc(nc1)C(F)(F)F)C(F)(F)F InChI=1S/C23H19F6N9O2S/c24-22(25,26)20-31-7-13(8-32-20)17-19(41-21(34-17)23(27,28)29)36-5-6-38(14(9-36)11-39)16(40)10-37-12-33-18(35-37)15-3-1-2-4-30-15/h1-4,7-8,12,14,39H,5-6,9-11H2 KXASRAWQPLSZAB-UHFFFAOYSA-N 610427 US10053457, Example 23::1-{(R)-2-Hydroxymethyl-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-2-(3-pyridin-2-yl-[1,2,4]triazol-1-yl)-ethanone C-X-C chemokine receptor type 3 Homo sapiens 35.0 US Patent 10.7270/Q2S46X2G aid1919602 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610427 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610427&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 135373414 483620592 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300166 CCc1nc(C)n(CC(=O)N2CCN(C[C@@H]2CO)c2sc(nc2-c2cnc(nc2)C(F)(F)F)C(F)(F)F)n1 InChI=1S/C21H22F6N8O2S/c1-3-14-30-11(2)35(32-14)9-15(37)34-5-4-33(8-13(34)10-36)17-16(31-19(38-17)21(25,26)27)12-6-28-18(29-7-12)20(22,23)24/h6-7,13,36H,3-5,8-10H2,1-2H3 JZHDUGWESPNADH-UHFFFAOYSA-N 610428 US10053457, Example 24::2-(3-Ethyl-5-methyl-[1,2,4]triazol-1-yl)-1-{(R)-2-hydroxymethyl-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-ethanone C-X-C chemokine receptor type 3 Homo sapiens 7.60 US Patent 10.7270/Q2S46X2G aid1919602 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610428 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610428&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485624 483620593 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300167 CCc1nc(C)nn1CC(=O)N1CCN(C[C@@H]1CO)c1sc(nc1-c1cnc(nc1)C(F)(F)F)C(F)(F)F InChI=1S/C21H22F6N8O2S/c1-3-14-30-11(2)32-35(14)9-15(37)34-5-4-33(8-13(34)10-36)17-16(31-19(38-17)21(25,26)27)12-6-28-18(29-7-12)20(22,23)24/h6-7,13,36H,3-5,8-10H2,1-2H3 MKFZBSCJKIDDTN-UHFFFAOYSA-N 610429 US10053457, Example 25::2-(5-Ethyl-3-methyl-[1,2,4]triazol-1-yl)-1-{(R)-2-hydroxymethyl-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-ethanone C-X-C chemokine receptor type 3 Homo sapiens 3.60 US Patent 10.7270/Q2S46X2G aid1919602 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610429 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610429&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485680 483620594 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300168 OC[C@H]1CN(CCN1C(=O)Cn1cnc2cccnc12)c1sc(nc1-c1cnc(nc1)C(F)(F)F)C(F)(F)F InChI=1S/C22H18F6N8O2S/c23-21(24,25)19-30-6-12(7-31-19)16-18(39-20(33-16)22(26,27)28)34-4-5-36(13(8-34)10-37)15(38)9-35-11-32-14-2-1-3-29-17(14)35/h1-3,6-7,11,13,37H,4-5,8-10H2 GUNZBIUHMICHNP-UHFFFAOYSA-N 610430 US10053457, Example 26::1-{(R)-2-Hydroxymethyl-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-2-imidazo[4,5-b]pyridin-3-yl-ethanone C-X-C chemokine receptor type 3 Homo sapiens 3.50 US Patent 10.7270/Q2S46X2G aid1919602 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610430 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610430&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485739 483620595 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300169 Cc1nc(C)n(CC(=O)N2CCN(C[C@H]2CCO)c2sc(nc2-c2cnc(nc2)C(F)(F)F)C(F)(F)F)n1 InChI=1S/C21H22F6N8O2S/c1-11-30-12(2)35(32-11)10-15(37)34-5-4-33(9-14(34)3-6-36)17-16(31-19(38-17)21(25,26)27)13-7-28-18(29-8-13)20(22,23)24/h7-8,14,36H,3-6,9-10H2,1-2H3 WXKHGTIVBDYLDP-UHFFFAOYSA-N 610431 US10053457, Example 27::2-(3,5-Dimethyl-[1,2,4]triazol-1-yl)-1-{(R)-2-(2-hydroxy-ethyl)-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-ethanone C-X-C chemokine receptor type 3 Homo sapiens 5.20 US Patent 10.7270/Q2S46X2G aid1919602 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610431 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610431&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485708 483620596 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300170 OCC[C@@H]1CN(CCN1C(=O)Cn1cnc(n1)C(F)(F)F)c1sc(nc1-c1cnc(nc1)C(F)(F)F)C(F)(F)F InChI=1S/C20H17F9N8O2S/c21-18(22,23)15-30-5-10(6-31-15)13-14(40-17(33-13)20(27,28)29)35-2-3-37(11(7-35)1-4-38)12(39)8-36-9-32-16(34-36)19(24,25)26/h5-6,9,11,38H,1-4,7-8H2 UHRJJAQULUVVNW-UHFFFAOYSA-N 610432 US10053457, Example 28::1-{(R)-2-(2-Hydroxy-ethyl)-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-2-(3-trifluoromethyl-[1,2,4]triazol-1-yl)-ethanone C-X-C chemokine receptor type 3 Homo sapiens 1.10 US Patent 10.7270/Q2S46X2G aid1919602 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610432 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610432&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 135373607 483620597 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300171 OCC[C@@H]1CN(CCN1C(=O)Cn1cnc(n1)C1CCC1)c1sc(nc1-c1cnc(nc1)C(F)(F)F)C(F)(F)F InChI=1S/C23H24F6N8O2S/c24-22(25,26)20-30-8-14(9-31-20)17-19(40-21(33-17)23(27,28)29)35-5-6-37(15(10-35)4-7-38)16(39)11-36-12-32-18(34-36)13-2-1-3-13/h8-9,12-13,15,38H,1-7,10-11H2 VLRFEBIMHLIKSV-UHFFFAOYSA-N 610433 US10053457, Example 29::2-(3-Cyclobutyl-[1,2,4]triazol-1-yl)-1-{(R)-2-(2-hydroxy-ethyl)-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-ethanone C-X-C chemokine receptor type 3 Homo sapiens 5.50 US Patent 10.7270/Q2S46X2G aid1919602 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610433 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610433&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485690 483620598 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300172 CC(C)(C)c1ncn(CC(=O)N2CCN(C[C@H]2CCO)c2sc(nc2-c2cnc(nc2)C(F)(F)F)C(F)(F)F)n1 InChI=1S/C23H26F6N8O2S/c1-21(2,3)18-32-12-36(34-18)11-15(39)37-6-5-35(10-14(37)4-7-38)17-16(33-20(40-17)23(27,28)29)13-8-30-19(31-9-13)22(24,25)26/h8-9,12,14,38H,4-7,10-11H2,1-3H3 LSVONHDRKPIPQA-UHFFFAOYSA-N 610434 US10053457, Example 30::2-(3-tert-Butyl-[1,2,4]triazol-1-yl)-1-{(R)-2-(2-hydroxy-ethyl)-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-ethanone C-X-C chemokine receptor type 3 Homo sapiens 4.40 US Patent 10.7270/Q2S46X2G aid1919602 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610434 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610434&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485654 483620599 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300173 OCC[C@@H]1CN(CCN1C(=O)Cn1cnc(n1)C1CC1)c1sc(nc1-c1cnc(nc1)C(F)(F)F)C(F)(F)F InChI=1S/C22H22F6N8O2S/c23-21(24,25)19-29-7-13(8-30-19)16-18(39-20(32-16)22(26,27)28)34-4-5-36(14(9-34)3-6-37)15(38)10-35-11-31-17(33-35)12-1-2-12/h7-8,11-12,14,37H,1-6,9-10H2 QCQXHPGCLHGFID-UHFFFAOYSA-N 610435 US10053457, Example 31::2-(3-Cyclopropyl-[1,2,4]triazol-1-yl)-1-{(R)-2-(2-hydroxy-ethyl)-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-ethanone C-X-C chemokine receptor type 3 Homo sapiens 4.40 US Patent 10.7270/Q2S46X2G aid1919602 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610435 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610435&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485676 483620600 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300174 CCc1ncn(CC(=O)N2CCN(C[C@H]2CCO)c2sc(nc2-c2cnc(nc2)C(F)(F)F)C(F)(F)F)n1 InChI=1S/C21H22F6N8O2S/c1-2-14-30-11-34(32-14)10-15(37)35-5-4-33(9-13(35)3-6-36)17-16(31-19(38-17)21(25,26)27)12-7-28-18(29-8-12)20(22,23)24/h7-8,11,13,36H,2-6,9-10H2,1H3 WYHMARFYRUASMT-UHFFFAOYSA-N 610436 US10053457, Example 32::2-(3-Ethyl-[1,2,4]triazol-1-yl)-1-{(R)-2-(2-hydroxy-ethyl)-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-ethanone C-X-C chemokine receptor type 3 Homo sapiens 2.60 US Patent 10.7270/Q2S46X2G aid1919602 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610436 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610436&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485726 483620601 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300175 CCc1ncnn1CC(=O)N1CCN(C[C@H]1CCO)c1sc(nc1-c1cnc(nc1)C(F)(F)F)C(F)(F)F InChI=1S/C21H22F6N8O2S/c1-2-14-30-11-31-35(14)10-15(37)34-5-4-33(9-13(34)3-6-36)17-16(32-19(38-17)21(25,26)27)12-7-28-18(29-8-12)20(22,23)24/h7-8,11,13,36H,2-6,9-10H2,1H3 AZXNOMHWUBIVHT-UHFFFAOYSA-N 610437 US10053457, Example 33::2-(5-Ethyl-[1,2,4]triazol-1-yl)-1-{(R)-2-(2-hydroxy-ethyl)-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-ethanone C-X-C chemokine receptor type 3 Homo sapiens 27.0 US Patent 10.7270/Q2S46X2G aid1919602 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610437 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610437&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485736 483620602 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300176 CC(C)c1ncn(CC(=O)N2CCN(C[C@H]2CCO)c2sc(nc2-c2cnc(nc2)C(F)(F)F)C(F)(F)F)n1 InChI=1S/C22H24F6N8O2S/c1-12(2)17-31-11-35(33-17)10-15(38)36-5-4-34(9-14(36)3-6-37)18-16(32-20(39-18)22(26,27)28)13-7-29-19(30-8-13)21(23,24)25/h7-8,11-12,14,37H,3-6,9-10H2,1-2H3 WFZUDDFKDDQSCZ-UHFFFAOYSA-N 610438 US10053457, Example 34::1-{(R)-2-(2-Hydroxy-ethyl)-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-2-(3-isopropyl-[1,2,4]triazol-1-yl)-ethanone C-X-C chemokine receptor type 3 Homo sapiens 4.50 US Patent 10.7270/Q2S46X2G aid1919602 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610438 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610438&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485691 483620603 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300177 Cc1ncn(CC(=O)N2CCN(C[C@H]2CCO)c2sc(nc2-c2cnc(nc2)C(F)(F)F)C(F)(F)F)n1 InChI=1S/C20H20F6N8O2S/c1-11-29-10-33(31-11)9-14(36)34-4-3-32(8-13(34)2-5-35)16-15(30-18(37-16)20(24,25)26)12-6-27-17(28-7-12)19(21,22)23/h6-7,10,13,35H,2-5,8-9H2,1H3 FDZFVXKCJKOSRC-UHFFFAOYSA-N 610439 US10053457, Example 35::1-{(R)-2-(2-Hydroxy-ethyl)-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-2-(3-methyl-[1,2,4]triazol-1-yl)-ethanone C-X-C chemokine receptor type 3 Homo sapiens 2.90 US Patent 10.7270/Q2S46X2G aid1919602 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610439 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610439&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485701 483620604 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300178 Cc1ncnn1CC(=O)N1CCN(C[C@H]1CCO)c1sc(nc1-c1cnc(nc1)C(F)(F)F)C(F)(F)F InChI=1S/C20H20F6N8O2S/c1-11-29-10-30-34(11)9-14(36)33-4-3-32(8-13(33)2-5-35)16-15(31-18(37-16)20(24,25)26)12-6-27-17(28-7-12)19(21,22)23/h6-7,10,13,35H,2-5,8-9H2,1H3 YELKCXZWNROAEF-UHFFFAOYSA-N 610440 US10053457, Example 36::1-{(R)-2-(2-Hydroxy-ethyl)-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-2-(5-methyl-[1,2,4]triazol-1-yl)-ethanone C-X-C chemokine receptor type 3 Homo sapiens 8.00 US Patent 10.7270/Q2S46X2G aid1919602 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610440 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610440&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485734 483620605 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300179 COCc1ncn(CC(=O)N2CCN(C[C@H]2CCO)c2sc(nc2-c2cnc(nc2)C(F)(F)F)C(F)(F)F)n1 InChI=1S/C21H22F6N8O3S/c1-38-10-14-30-11-34(32-14)9-15(37)35-4-3-33(8-13(35)2-5-36)17-16(31-19(39-17)21(25,26)27)12-6-28-18(29-7-12)20(22,23)24/h6-7,11,13,36H,2-5,8-10H2,1H3 AFDXSDJIFGITNV-UHFFFAOYSA-N 610441 US10053457, Example 37::1-{(R)-2-(2-Hydroxy-ethyl)-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-2-(3-methoxymethyl-[1,2,4]triazol-1-yl)-ethanone C-X-C chemokine receptor type 3 Homo sapiens 5.70 US Patent 10.7270/Q2S46X2G aid1919602 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610441 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610441&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 135373703 483620606 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300180 OC[C@H]1CN(CCN1C(=O)Cn1cnc(n1)C(F)F)c1sc(nc1-c1cnc(nc1)C(F)(F)F)C(F)(F)F InChI=1S/C19H16F8N8O2S/c20-13(21)14-30-8-34(32-14)6-11(37)35-2-1-33(5-10(35)7-36)15-12(31-17(38-15)19(25,26)27)9-3-28-16(29-4-9)18(22,23)24/h3-4,8,10,13,36H,1-2,5-7H2 QPYREERGLRDOSN-UHFFFAOYSA-N 610442 US10053457, Example 38::2-(3-Difluoromethyl-[1,2,4]triazol-1-yl)-1-{(R)-2-hydroxymethyl-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-ethanone C-X-C chemokine receptor type 3 Homo sapiens 8.60 US Patent 10.7270/Q2S46X2G aid1919602 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610442 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610442&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485653 483620607 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300181 Cc1ccn(CC(=O)N2CCN(C[C@H]2CCO)c2sc(nc2-c2cnc(nc2)C(F)(F)F)C(F)(F)F)n1 InChI=1S/C21H21F6N7O2S/c1-12-2-4-33(31-12)11-15(36)34-6-5-32(10-14(34)3-7-35)17-16(30-19(37-17)21(25,26)27)13-8-28-18(29-9-13)20(22,23)24/h2,4,8-9,14,35H,3,5-7,10-11H2,1H3 NTFKMMZGMLEXET-UHFFFAOYSA-N 610443 US10053457, Example 39::1-{(R)-2-(2-Hydroxy-ethyl)-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-2-(3-methyl-pyrazol-1-yl)-ethanone C-X-C chemokine receptor type 3 Homo sapiens 1.000 US Patent 10.7270/Q2S46X2G aid1919602 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610443 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610443&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485718 483620608 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300182 CCc1ccn(CC(=O)N2CCN(C[C@H]2CCO)c2sc(nc2-c2cnc(nc2)C(F)(F)F)C(F)(F)F)n1 InChI=1S/C22H23F6N7O2S/c1-2-14-3-5-34(32-14)12-16(37)35-7-6-33(11-15(35)4-8-36)18-17(31-20(38-18)22(26,27)28)13-9-29-19(30-10-13)21(23,24)25/h3,5,9-10,15,36H,2,4,6-8,11-12H2,1H3 LEHFCHSREMRJMI-UHFFFAOYSA-N 610444 US10053457, Example 40::2-(3-Ethyl-pyrazol-1-yl)-1-{(R)-2-(2-hydroxy-ethyl)-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-ethanone C-X-C chemokine receptor type 3 Homo sapiens 1.60 US Patent 10.7270/Q2S46X2G aid1919602 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610444 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610444&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485628 483620609 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300183 OCC[C@@H]1CN(CCN1C(=O)Cn1ccc(n1)C1CC1)c1sc(nc1-c1cnc(nc1)C(F)(F)F)C(F)(F)F InChI=1S/C23H23F6N7O2S/c24-22(25,26)20-30-9-14(10-31-20)18-19(39-21(32-18)23(27,28)29)34-6-7-36(15(11-34)4-8-37)17(38)12-35-5-3-16(33-35)13-1-2-13/h3,5,9-10,13,15,37H,1-2,4,6-8,11-12H2 YTLUUFZLGZMZDK-UHFFFAOYSA-N 610445 US10053457, Example 41::2-(3-Cyclopropyl-pyrazol-1-yl)-1-{(R)-2-(2-hydroxy-ethyl)-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-ethanone C-X-C chemokine receptor type 3 Homo sapiens 0.450 US Patent 10.7270/Q2S46X2G aid1919602 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610445 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610445&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485700 483620610 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300184 Cc1ccn(CC(=O)N2CCN(C[C@H]2CO)c2sc(nc2-c2cnc(nc2)C(F)(F)F)C(F)(F)F)n1 InChI=1S/C20H19F6N7O2S/c1-11-2-3-32(30-11)9-14(35)33-5-4-31(8-13(33)10-34)16-15(29-18(36-16)20(24,25)26)12-6-27-17(28-7-12)19(21,22)23/h2-3,6-7,13,34H,4-5,8-10H2,1H3 GQQMDOGXIJRPDK-UHFFFAOYSA-N 610446 US10053457, Example 42::1-{(S)-2-Hydroxymethyl-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-2-(3-methyl-pyrazol-1-yl)-ethanone C-X-C chemokine receptor type 3 Homo sapiens 1.000 US Patent 10.7270/Q2S46X2G aid1919602 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610446 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610446&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485651 483620611 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300185 CCc1ccn(CC(=O)N2CCN(C[C@H]2CO)c2sc(nc2-c2cnc(nc2)C(F)(F)F)C(F)(F)F)n1 InChI=1S/C21H21F6N7O2S/c1-2-13-3-4-33(31-13)10-15(36)34-6-5-32(9-14(34)11-35)17-16(30-19(37-17)21(25,26)27)12-7-28-18(29-8-12)20(22,23)24/h3-4,7-8,14,35H,2,5-6,9-11H2,1H3 AYNOFJPXPRZEFF-UHFFFAOYSA-N 610448 US10053457, Example 43::2-(3-Ethyl-pyrazol-1-yl)-1-{(S)-2-hydroxymethyl-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-ethanone C-X-C chemokine receptor type 3 Homo sapiens 1.20 US Patent 10.7270/Q2S46X2G aid1919602 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610448 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610448&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485731 483620613 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300186 OC[C@@H]1CN(CCN1C(=O)Cn1ccc(n1)C1CC1)c1sc(nc1-c1cnc(nc1)C(F)(F)F)C(F)(F)F InChI=1S/C22H21F6N7O2S/c23-21(24,25)19-29-7-13(8-30-19)17-18(38-20(31-17)22(26,27)28)33-5-6-35(14(9-33)11-36)16(37)10-34-4-3-15(32-34)12-1-2-12/h3-4,7-8,12,14,36H,1-2,5-6,9-11H2 XLDNJQXRMYVGDR-UHFFFAOYSA-N 610449 US10053457, Example 44::2-(3-Cyclopropyl-pyrazol-1-yl)-1-{(S)-2-hydroxymethyl-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-ethanone C-X-C chemokine receptor type 3 Homo sapiens 0.380 US Patent 10.7270/Q2S46X2G aid1919602 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610449 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610449&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485722 483620614 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300187 CC(C)(C)c1ncn(CC(=O)N2CCN(C[C@H]2CO)c2sc(nc2-c2cnc(nc2)C(F)(F)F)C(F)(F)F)n1 InChI=1S/C22H24F6N8O2S/c1-20(2,3)17-31-11-35(33-17)9-14(38)36-5-4-34(8-13(36)10-37)16-15(32-19(39-16)22(26,27)28)12-6-29-18(30-7-12)21(23,24)25/h6-7,11,13,37H,4-5,8-10H2,1-3H3 ZXSLRBPBMBEVPN-UHFFFAOYSA-N 610020 US10053457, Example 1::2-(3-tert-Butyl-[1,2,4]triazol-1-yl)-1-{(S)-2-hydroxymethyl-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-ethanone C-X-C chemokine receptor type 3 Homo sapiens 415 US Patent 10.7270/Q2S46X2G aid1919603 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610020 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610020&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485668 483620187 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300188 Cc1nc(C)n(CC(=O)N2CCN(C[C@H]2CO)c2sc(nc2-c2cnc(nc2)C(F)(F)F)C(F)(F)F)n1 InChI=1S/C20H20F6N8O2S/c1-10-29-11(2)34(31-10)8-14(36)33-4-3-32(7-13(33)9-35)16-15(30-18(37-16)20(24,25)26)12-5-27-17(28-6-12)19(21,22)23/h5-6,13,35H,3-4,7-9H2,1-2H3 UNBODQFVLQNKLE-UHFFFAOYSA-N 610021 US10053457, Example 2::2-(3,5-Dimethyl-[1,2,4]triazol-1-yl)-1-{(S)-2-hydroxymethyl-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-ethanone C-X-C chemokine receptor type 3 Homo sapiens 463 US Patent 10.7270/Q2S46X2G aid1919603 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610021 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610021&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485652 483620188 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300189 OC[C@@H]1CN(CCN1C(=O)Cn1cnc(n1)C1CC1)c1sc(nc1-c1cnc(nc1)C(F)(F)F)C(F)(F)F InChI=1S/C21H20F6N8O2S/c22-20(23,24)18-28-5-12(6-29-18)15-17(38-19(31-15)21(25,26)27)33-3-4-35(13(7-33)9-36)14(37)8-34-10-30-16(32-34)11-1-2-11/h5-6,10-11,13,36H,1-4,7-9H2 DAFKTUHZZXUBLN-UHFFFAOYSA-N 610068 US10053457, Example 3::2-(3-Cyclopropyl-[1,2,4]triazol-1-yl)-1-{(S)-2-hydroxymethyl-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-ethanone C-X-C chemokine receptor type 3 Homo sapiens 191 US Patent 10.7270/Q2S46X2G aid1919603 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610068 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610068&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485715 483620235 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300190 CC(C)c1ncn(CC(=O)N2CCN(C[C@H]2CO)c2sc(nc2-c2cnc(nc2)C(F)(F)F)C(F)(F)F)n1 InChI=1S/C21H22F6N8O2S/c1-11(2)16-30-10-34(32-16)8-14(37)35-4-3-33(7-13(35)9-36)17-15(31-19(38-17)21(25,26)27)12-5-28-18(29-6-12)20(22,23)24/h5-6,10-11,13,36H,3-4,7-9H2,1-2H3 BHWGZPATDOVSCG-UHFFFAOYSA-N 610138 US10053457, Example 4::1-{(S)-2-Hydroxymethyl-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-2-(3-isopropyl-[1,2,4]triazol-1-yl)-ethanone C-X-C chemokine receptor type 3 Homo sapiens 283 US Patent 10.7270/Q2S46X2G aid1919603 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610138 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610138&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485723 483620304 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300191 OC[C@@H]1CN(CCN1C(=O)Cn1cnc(n1)C(F)(F)F)c1sc(nc1-c1cnc(nc1)C(F)(F)F)C(F)(F)F InChI=1S/C19H15F9N8O2S/c20-17(21,22)14-29-3-9(4-30-14)12-13(39-16(32-12)19(26,27)28)34-1-2-36(10(5-34)7-37)11(38)6-35-8-31-15(33-35)18(23,24)25/h3-4,8,10,37H,1-2,5-7H2 LZBLSLKZLJWLQF-UHFFFAOYSA-N 610160 US10053457, Example 5::1-{(S)-2-Hydroxymethyl-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-2-(3-trifluoromethyl-[1,2,4]triazol-1-yl)-ethanone C-X-C chemokine receptor type 3 Homo sapiens 328 US Patent 10.7270/Q2S46X2G aid1919603 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610160 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610160&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485687 483620325 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300192 CCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](CO)C1)C(=O)Cn1cnc(n1)C(F)(F)F)C(F)(F)F InChI=1S/C20H20F6N8O3S/c1-2-37-18-27-5-11(6-28-18)14-15(38-17(30-14)20(24,25)26)32-3-4-34(12(7-32)9-35)13(36)8-33-10-29-16(31-33)19(21,22)23/h5-6,10,12,35H,2-4,7-9H2,1H3 KAZYZPSVWIJVCD-UHFFFAOYSA-N 610186 US10053457, Example 6::1-{(S)-4-[4-(2-Ethoxy-pyrimidin-5-yl)-2-trifluoromethyl-thiazol-5-yl]-2-hydroxymethyl-piperazin-1-yl}-2-(3-trifluoromethyl-[1,2,4]triazol-1-yl)-ethanone C-X-C chemokine receptor type 3 Homo sapiens 778 US Patent 10.7270/Q2S46X2G aid1919603 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610186 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610186&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485694 483620351 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300193 CCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](CO)C1)C(=O)Cn1nc(C)nc1C)C(F)(F)F InChI=1S/C21H25F3N8O3S/c1-4-35-20-25-7-14(8-26-20)17-18(36-19(28-17)21(22,23)24)30-5-6-31(15(9-30)11-33)16(34)10-32-13(3)27-12(2)29-32/h7-8,15,33H,4-6,9-11H2,1-3H3 KZIASVKYOSOUFZ-UHFFFAOYSA-N 610188 US10053457, Example 7::2-(3,5-Dimethyl-[1,2,4]triazol-1-yl)-1-{(S)-4-[4-(2-ethoxy-pyrimidin-5-yl)-2-trifluoromethyl-thiazol-5-yl]-2-hydroxymethyl-piperazin-1-yl}-ethanone C-X-C chemokine receptor type 3 Homo sapiens 2270 US Patent 10.7270/Q2S46X2G aid1919603 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610188 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610188&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485681 483620353 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300194 Cc1nc(C)n(CC(=O)N2CCN(C[C@H]2CO)c2sc(nc2-c2cnc(nc2)C2CC2)C(F)(F)F)n1 InChI=1S/C22H25F3N8O2S/c1-12-28-13(2)33(30-12)10-17(35)32-6-5-31(9-16(32)11-34)20-18(29-21(36-20)22(23,24)25)15-7-26-19(27-8-15)14-3-4-14/h7-8,14,16,34H,3-6,9-11H2,1-2H3 ZGISBRGPKNASOI-UHFFFAOYSA-N 610196 US10053457, Example 8::1-{(S)-4-[4-(2-Cyclopropyl-pyrimidin-5-yl)-2-trifluoromethyl-thiazol-5-yl]-2-hydroxymethyl-piperazin-1-yl}-2-(3,5-di methyl-[1,2,4]triazol-1-yl)-ethanone C-X-C chemokine receptor type 3 Homo sapiens 3200 US Patent 10.7270/Q2S46X2G aid1919603 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610196 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610196&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485637 483620361 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300195 OC[C@@H]1CN(CCN1C(=O)Cn1cnc(n1)C(F)(F)F)c1sc(nc1-c1cnc(nc1)C1CC1)C(F)(F)F InChI=1S/C21H20F6N8O2S/c22-20(23,24)18-30-10-34(32-18)8-14(37)35-4-3-33(7-13(35)9-36)17-15(31-19(38-17)21(25,26)27)12-5-28-16(29-6-12)11-1-2-11/h5-6,10-11,13,36H,1-4,7-9H2 DQFRAXJGMQALQK-UHFFFAOYSA-N 610381 US10053457, Example 9::1-{(S)-4-[4-(2-Cyclopropyl-pyrimidin-5-yl)-2-trifluoromethyl-thiazol-5-yl]-2-hydroxymethyl-piperazin-1-yl}-2-(3-trifluoromethyl-[1,2,4]triazol-1-yl)-ethanone C-X-C chemokine receptor type 3 Homo sapiens 1520 US Patent 10.7270/Q2S46X2G aid1919603 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610381 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610381&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485711 483620546 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300196 CC(C)c1ncn(CC(=O)N2CCN(C[C@@H]2CO)c2sc(nc2-c2ccc(nc2)C(F)(F)F)C(F)(F)F)n1 InChI=1S/C22H23F6N7O2S/c1-12(2)18-30-11-34(32-18)9-16(37)35-6-5-33(8-14(35)10-36)19-17(31-20(38-19)22(26,27)28)13-3-4-15(29-7-13)21(23,24)25/h3-4,7,11-12,14,36H,5-6,8-10H2,1-2H3 QTGXTHMTKKQHMR-UHFFFAOYSA-N 610414 US10053457, Example 10::1-{(R)-2-Hydroxymethyl-4-[2-trifluoromethyl-4-(6-trifluoromethyl-pyridin-3-yl)-thiazol-5-yl]-piperazin-1-yl}-2-(3-isopropyl-[1,2,4]triazol-1-yl)-ethanone C-X-C chemokine receptor type 3 Homo sapiens 961 US Patent 10.7270/Q2S46X2G aid1919603 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610414 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610414&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485728 483620579 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300197 CC(C)c1ncn(CC(=O)N2CCN(C[C@@H]2CO)c2sc(nc2-c2cnc(nc2)C(F)(F)F)C(F)(F)F)n1 InChI=1S/C21H22F6N8O2S/c1-11(2)16-30-10-34(32-16)8-14(37)35-4-3-33(7-13(35)9-36)17-15(31-19(38-17)21(25,26)27)12-5-28-18(29-6-12)20(22,23)24/h5-6,10-11,13,36H,3-4,7-9H2,1-2H3 BHWGZPATDOVSCG-UHFFFAOYSA-N 610415 US10053457, Example 11::1-{(R)-2-Hydroxymethyl-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-2-(3-isopropyl-[1,2,4]triazol-1-yl)-ethanone C-X-C chemokine receptor type 3 Homo sapiens 339 US Patent 10.7270/Q2S46X2G aid1919603 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610415 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610415&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485695 483620580 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300198 Cc1nc(C)n(CC(=O)N2CCN(C[C@@H]2CO)c2sc(nc2-c2cnc(nc2)C(F)(F)F)C(F)(F)F)n1 InChI=1S/C20H20F6N8O2S/c1-10-29-11(2)34(31-10)8-14(36)33-4-3-32(7-13(33)9-35)16-15(30-18(37-16)20(24,25)26)12-5-27-17(28-6-12)19(21,22)23/h5-6,13,35H,3-4,7-9H2,1-2H3 UNBODQFVLQNKLE-UHFFFAOYSA-N 610416 US10053457, Example 12::2-(3,5-Dimethyl-[1,2,4]triazol-1-yl)-1-{(R)-2-hydroxymethyl-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-ethanone C-X-C chemokine receptor type 3 Homo sapiens 324 US Patent 10.7270/Q2S46X2G aid1919603 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610416 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610416&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485710 483620581 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300199 OC[C@H]1CN(CCN1C(=O)Cn1cnc2ccccc12)c1sc(nc1-c1cnc(nc1)C(F)(F)F)C(F)(F)F InChI=1S/C23H19F6N7O2S/c24-22(25,26)20-30-7-13(8-31-20)18-19(39-21(33-18)23(27,28)29)34-5-6-36(14(9-34)11-37)17(38)10-35-12-32-15-3-1-2-4-16(15)35/h1-4,7-8,12,14,37H,5-6,9-11H2 WFYDWTNVQOVKAZ-UHFFFAOYSA-N 610417 US10053457, Example 13::2-Benzoimidazol-1-yl-1-{(R)-2-hydroxymethyl-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-ethanone C-X-C chemokine receptor type 3 Homo sapiens 1050 US Patent 10.7270/Q2S46X2G aid1919603 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610417 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610417&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485719 483620582 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300200 OC[C@H]1CN(CCN1C(=O)Cn1ccc2cc(F)ccc12)c1sc(nc1-c1cnc(nc1)C(F)(F)F)C(F)(F)F InChI=1S/C24H19F7N6O2S/c25-15-1-2-17-13(7-15)3-4-35(17)11-18(39)37-6-5-36(10-16(37)12-38)20-19(34-22(40-20)24(29,30)31)14-8-32-21(33-9-14)23(26,27)28/h1-4,7-9,16,38H,5-6,10-12H2 LQRHNGOTLMNBKG-UHFFFAOYSA-N 610418 US10053457, Example 14::2-(5-Fluoro-indol-1-yl)-1-{(R)-2-hydroxymethyl-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-ethanone C-X-C chemokine receptor type 3 Homo sapiens 199 US Patent 10.7270/Q2S46X2G aid1919603 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610418 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610418&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485664 483620583 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300201 COc1ccc2n(CC(=O)N3CCN(C[C@@H]3CO)c3sc(nc3-c3cnc(nc3)C(F)(F)F)C(F)(F)F)ccc2c1 InChI=1S/C25H22F6N6O3S/c1-40-17-2-3-18-14(8-17)4-5-35(18)12-19(39)37-7-6-36(11-16(37)13-38)21-20(34-23(41-21)25(29,30)31)15-9-32-22(33-10-15)24(26,27)28/h2-5,8-10,16,38H,6-7,11-13H2,1H3 USNOADPXDZVWHO-UHFFFAOYSA-N 610419 US10053457, Example 15::1-{(R)-2-Hydroxymethyl-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-2-(5-methoxy-indol-1-yl)-ethanone C-X-C chemokine receptor type 3 Homo sapiens 1660 US Patent 10.7270/Q2S46X2G aid1919603 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610419 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610419&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485725 483620584 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300202 Cc1ncn(CC(=O)N2CCN(C[C@@H]2CO)c2sc(nc2-c2cnc(nc2)C(F)(F)F)C(F)(F)F)n1 InChI=1S/C19H18F6N8O2S/c1-10-28-9-32(30-10)7-13(35)33-3-2-31(6-12(33)8-34)15-14(29-17(36-15)19(23,24)25)11-4-26-16(27-5-11)18(20,21)22/h4-5,9,12,34H,2-3,6-8H2,1H3 YZWIMDHUANZMQA-UHFFFAOYSA-N 610420 US10053457, Example 16::1-{(R)-2-Hydroxymethyl-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-2-(3-methyl-[1,2,4]triazol-1-yl)-ethanone C-X-C chemokine receptor type 3 Homo sapiens 542 US Patent 10.7270/Q2S46X2G aid1919603 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610420 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610420&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485714 483620585 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300203 COCc1ncn(CC(=O)N2CCN(C[C@@H]2CO)c2sc(nc2-c2cnc(nc2)C(F)(F)F)C(F)(F)F)n1 InChI=1S/C20H20F6N8O3S/c1-37-9-13-29-10-33(31-13)7-14(36)34-3-2-32(6-12(34)8-35)16-15(30-18(38-16)20(24,25)26)11-4-27-17(28-5-11)19(21,22)23/h4-5,10,12,35H,2-3,6-9H2,1H3 RJEBPSVBZFRUQD-UHFFFAOYSA-N 610421 US10053457, Example 17::1-{(R)-2-Hydroxymethyl-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-2-(3-methoxymethyl-[1,2,4]triazol-1-yl)-ethanone C-X-C chemokine receptor type 3 Homo sapiens 1290 US Patent 10.7270/Q2S46X2G aid1919603 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610421 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610421&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 135373609 483620586 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300204 Cc1nc(no1)-c1ncn(CC(=O)N2CCN(C[C@@H]2CO)c2sc(nc2-c2cnc(nc2)C(F)(F)F)C(F)(F)F)n1 InChI=1S/C21H18F6N10O3S/c1-10-31-16(34-40-10)15-30-9-36(33-15)7-13(39)37-3-2-35(6-12(37)8-38)17-14(32-19(41-17)21(25,26)27)11-4-28-18(29-5-11)20(22,23)24/h4-5,9,12,38H,2-3,6-8H2,1H3 QYOBFBGMFZFQAQ-UHFFFAOYSA-N 610422 US10053457, Example 18::1-{(R)-2-Hydroxymethyl-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-2-[3-(5-methyl-[1,2,4]oxadiazol-3-yl)-[1,2,4]triazol-1-yl]-ethanone C-X-C chemokine receptor type 3 Homo sapiens 6500 US Patent 10.7270/Q2S46X2G aid1919603 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610422 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610422&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485743 483620587 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300205 OC[C@H]1CN(CCN1C(=O)Cn1cnc(n1)-c1ccccc1)c1sc(nc1-c1cnc(nc1)C(F)(F)F)C(F)(F)F InChI=1S/C24H20F6N8O2S/c25-23(26,27)21-31-8-15(9-32-21)18-20(41-22(34-18)24(28,29)30)36-6-7-38(16(10-36)12-39)17(40)11-37-13-33-19(35-37)14-4-2-1-3-5-14/h1-5,8-9,13,16,39H,6-7,10-12H2 HSXNORDTRMEGJR-UHFFFAOYSA-N 610423 US10053457, Example 19::1-{(R)-2-Hydroxymethyl-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-2-(3-phenyl-[1,2,4]triazol-1-yl)-ethanone C-X-C chemokine receptor type 3 Homo sapiens 3310 US Patent 10.7270/Q2S46X2G aid1919603 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610423 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610423&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485702 483620588 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300206 CC(=O)c1ncn(CC(=O)N2CCN(C[C@@H]2CO)c2sc(nc2-c2cnc(nc2)C(F)(F)F)C(F)(F)F)n1 InChI=1S/C20H18F6N8O3S/c1-10(36)15-29-9-33(31-15)7-13(37)34-3-2-32(6-12(34)8-35)16-14(30-18(38-16)20(24,25)26)11-4-27-17(28-5-11)19(21,22)23/h4-5,9,12,35H,2-3,6-8H2,1H3 DWFGJTJGAFWCDN-UHFFFAOYSA-N 610424 US10053457, Example 20::2-(3-Acetyl-[1,2,4]triazol-1-yl)-1-{(R)-2-hydroxymethyl-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-ethanone C-X-C chemokine receptor type 3 Homo sapiens 2380 US Patent 10.7270/Q2S46X2G aid1919603 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610424 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610424&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485663 483620589 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300207 CC(O)c1ncn(CC(=O)N2CCN(C[C@@H]2CO)c2sc(nc2-c2cnc(nc2)C(F)(F)F)C(F)(F)F)n1 InChI=1S/C20H20F6N8O3S/c1-10(36)15-29-9-33(31-15)7-13(37)34-3-2-32(6-12(34)8-35)16-14(30-18(38-16)20(24,25)26)11-4-27-17(28-5-11)19(21,22)23/h4-5,9-10,12,35-36H,2-3,6-8H2,1H3 GLRPZUMNSOSOFU-UHFFFAOYSA-N 610425 US10053457, Example 21::2-[3-(1-Hydroxy-ethyl)-[1,2,4]triazol-1-yl]-1-{(R)-2-hydroxymethyl-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-ethanone C-X-C chemokine receptor type 3 Homo sapiens 737 US Patent 10.7270/Q2S46X2G aid1919603 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610425 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610425&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485675 483620590 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300208 Cc1ccn(CC(=O)N2CCN(C[C@@H]2CO)c2sc(nc2-c2cnc(nc2)C(F)(F)F)C(F)(F)F)n1 InChI=1S/C20H19F6N7O2S/c1-11-2-3-32(30-11)9-14(35)33-5-4-31(8-13(33)10-34)16-15(29-18(36-16)20(24,25)26)12-6-27-17(28-7-12)19(21,22)23/h2-3,6-7,13,34H,4-5,8-10H2,1H3 GQQMDOGXIJRPDK-UHFFFAOYSA-N 610426 US10053457, Example 22::1-{(R)-2-Hydroxymethyl-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-2-(3-methyl-pyrazol-1-yl)-ethanone C-X-C chemokine receptor type 3 Homo sapiens 105 US Patent 10.7270/Q2S46X2G aid1919603 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610426 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610426&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485632 483620591 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300209 OC[C@H]1CN(CCN1C(=O)Cn1cnc(n1)-c1ccccn1)c1sc(nc1-c1cnc(nc1)C(F)(F)F)C(F)(F)F InChI=1S/C23H19F6N9O2S/c24-22(25,26)20-31-7-13(8-32-20)17-19(41-21(34-17)23(27,28)29)36-5-6-38(14(9-36)11-39)16(40)10-37-12-33-18(35-37)15-3-1-2-4-30-15/h1-4,7-8,12,14,39H,5-6,9-11H2 KXASRAWQPLSZAB-UHFFFAOYSA-N 610427 US10053457, Example 23::1-{(R)-2-Hydroxymethyl-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-2-(3-pyridin-2-yl-[1,2,4]triazol-1-yl)-ethanone C-X-C chemokine receptor type 3 Homo sapiens 2730 US Patent 10.7270/Q2S46X2G aid1919603 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610427 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610427&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 135373414 483620592 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300210 CCc1nc(C)n(CC(=O)N2CCN(C[C@@H]2CO)c2sc(nc2-c2cnc(nc2)C(F)(F)F)C(F)(F)F)n1 InChI=1S/C21H22F6N8O2S/c1-3-14-30-11(2)35(32-14)9-15(37)34-5-4-33(8-13(34)10-36)17-16(31-19(38-17)21(25,26)27)12-6-28-18(29-7-12)20(22,23)24/h6-7,13,36H,3-5,8-10H2,1-2H3 JZHDUGWESPNADH-UHFFFAOYSA-N 610428 US10053457, Example 24::2-(3-Ethyl-5-methyl-[1,2,4]triazol-1-yl)-1-{(R)-2-hydroxymethyl-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-ethanone C-X-C chemokine receptor type 3 Homo sapiens 355 US Patent 10.7270/Q2S46X2G aid1919603 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610428 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610428&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485624 483620593 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300211 CCc1nc(C)nn1CC(=O)N1CCN(C[C@@H]1CO)c1sc(nc1-c1cnc(nc1)C(F)(F)F)C(F)(F)F InChI=1S/C21H22F6N8O2S/c1-3-14-30-11(2)32-35(14)9-15(37)34-5-4-33(8-13(34)10-36)17-16(31-19(38-17)21(25,26)27)12-6-28-18(29-7-12)20(22,23)24/h6-7,13,36H,3-5,8-10H2,1-2H3 MKFZBSCJKIDDTN-UHFFFAOYSA-N 610429 US10053457, Example 25::2-(5-Ethyl-3-methyl-[1,2,4]triazol-1-yl)-1-{(R)-2-hydroxymethyl-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-ethanone C-X-C chemokine receptor type 3 Homo sapiens 664 US Patent 10.7270/Q2S46X2G aid1919603 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610429 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610429&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485680 483620594 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300212 OC[C@H]1CN(CCN1C(=O)Cn1cnc2cccnc12)c1sc(nc1-c1cnc(nc1)C(F)(F)F)C(F)(F)F InChI=1S/C22H18F6N8O2S/c23-21(24,25)19-30-6-12(7-31-19)16-18(39-20(33-16)22(26,27)28)34-4-5-36(13(8-34)10-37)15(38)9-35-11-32-14-2-1-3-29-17(14)35/h1-3,6-7,11,13,37H,4-5,8-10H2 GUNZBIUHMICHNP-UHFFFAOYSA-N 610430 US10053457, Example 26::1-{(R)-2-Hydroxymethyl-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-2-imidazo[4,5-b]pyridin-3-yl-ethanone C-X-C chemokine receptor type 3 Homo sapiens 74.2 US Patent 10.7270/Q2S46X2G aid1919603 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610430 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610430&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485739 483620595 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300213 Cc1nc(C)n(CC(=O)N2CCN(C[C@H]2CCO)c2sc(nc2-c2cnc(nc2)C(F)(F)F)C(F)(F)F)n1 InChI=1S/C21H22F6N8O2S/c1-11-30-12(2)35(32-11)10-15(37)34-5-4-33(9-14(34)3-6-36)17-16(31-19(38-17)21(25,26)27)13-7-28-18(29-8-13)20(22,23)24/h7-8,14,36H,3-6,9-10H2,1-2H3 WXKHGTIVBDYLDP-UHFFFAOYSA-N 610431 US10053457, Example 27::2-(3,5-Dimethyl-[1,2,4]triazol-1-yl)-1-{(R)-2-(2-hydroxy-ethyl)-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-ethanone C-X-C chemokine receptor type 3 Homo sapiens 235 US Patent 10.7270/Q2S46X2G aid1919603 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610431 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610431&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485708 483620596 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300214 OCC[C@@H]1CN(CCN1C(=O)Cn1cnc(n1)C(F)(F)F)c1sc(nc1-c1cnc(nc1)C(F)(F)F)C(F)(F)F InChI=1S/C20H17F9N8O2S/c21-18(22,23)15-30-5-10(6-31-15)13-14(40-17(33-13)20(27,28)29)35-2-3-37(11(7-35)1-4-38)12(39)8-36-9-32-16(34-36)19(24,25)26/h5-6,9,11,38H,1-4,7-8H2 UHRJJAQULUVVNW-UHFFFAOYSA-N 610432 US10053457, Example 28::1-{(R)-2-(2-Hydroxy-ethyl)-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-2-(3-trifluoromethyl-[1,2,4]triazol-1-yl)-ethanone C-X-C chemokine receptor type 3 Homo sapiens 214 US Patent 10.7270/Q2S46X2G aid1919603 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610432 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610432&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 135373607 483620597 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300215 OCC[C@@H]1CN(CCN1C(=O)Cn1cnc(n1)C1CCC1)c1sc(nc1-c1cnc(nc1)C(F)(F)F)C(F)(F)F InChI=1S/C23H24F6N8O2S/c24-22(25,26)20-30-8-14(9-31-20)17-19(40-21(33-17)23(27,28)29)35-5-6-37(15(10-35)4-7-38)16(39)11-36-12-32-18(34-36)13-2-1-3-13/h8-9,12-13,15,38H,1-7,10-11H2 VLRFEBIMHLIKSV-UHFFFAOYSA-N 610433 US10053457, Example 29::2-(3-Cyclobutyl-[1,2,4]triazol-1-yl)-1-{(R)-2-(2-hydroxy-ethyl)-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-ethanone C-X-C chemokine receptor type 3 Homo sapiens 157 US Patent 10.7270/Q2S46X2G aid1919603 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610433 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610433&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485690 483620598 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300216 CC(C)(C)c1ncn(CC(=O)N2CCN(C[C@H]2CCO)c2sc(nc2-c2cnc(nc2)C(F)(F)F)C(F)(F)F)n1 InChI=1S/C23H26F6N8O2S/c1-21(2,3)18-32-12-36(34-18)11-15(39)37-6-5-35(10-14(37)4-7-38)17-16(33-20(40-17)23(27,28)29)13-8-30-19(31-9-13)22(24,25)26/h8-9,12,14,38H,4-7,10-11H2,1-3H3 LSVONHDRKPIPQA-UHFFFAOYSA-N 610434 US10053457, Example 30::2-(3-tert-Butyl-[1,2,4]triazol-1-yl)-1-{(R)-2-(2-hydroxy-ethyl)-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-ethanone C-X-C chemokine receptor type 3 Homo sapiens 170 US Patent 10.7270/Q2S46X2G aid1919603 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610434 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610434&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485654 483620599 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300217 OCC[C@@H]1CN(CCN1C(=O)Cn1cnc(n1)C1CC1)c1sc(nc1-c1cnc(nc1)C(F)(F)F)C(F)(F)F InChI=1S/C22H22F6N8O2S/c23-21(24,25)19-29-7-13(8-30-19)16-18(39-20(32-16)22(26,27)28)34-4-5-36(14(9-34)3-6-37)15(38)10-35-11-31-17(33-35)12-1-2-12/h7-8,11-12,14,37H,1-6,9-10H2 QCQXHPGCLHGFID-UHFFFAOYSA-N 610435 US10053457, Example 31::2-(3-Cyclopropyl-[1,2,4]triazol-1-yl)-1-{(R)-2-(2-hydroxy-ethyl)-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-ethanone C-X-C chemokine receptor type 3 Homo sapiens 73.8 US Patent 10.7270/Q2S46X2G aid1919603 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610435 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610435&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485676 483620600 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300218 CCc1ncn(CC(=O)N2CCN(C[C@H]2CCO)c2sc(nc2-c2cnc(nc2)C(F)(F)F)C(F)(F)F)n1 InChI=1S/C21H22F6N8O2S/c1-2-14-30-11-34(32-14)10-15(37)35-5-4-33(9-13(35)3-6-36)17-16(31-19(38-17)21(25,26)27)12-7-28-18(29-8-12)20(22,23)24/h7-8,11,13,36H,2-6,9-10H2,1H3 WYHMARFYRUASMT-UHFFFAOYSA-N 610436 US10053457, Example 32::2-(3-Ethyl-[1,2,4]triazol-1-yl)-1-{(R)-2-(2-hydroxy-ethyl)-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-ethanone C-X-C chemokine receptor type 3 Homo sapiens 93.3 US Patent 10.7270/Q2S46X2G aid1919603 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610436 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610436&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485726 483620601 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300219 CCc1ncnn1CC(=O)N1CCN(C[C@H]1CCO)c1sc(nc1-c1cnc(nc1)C(F)(F)F)C(F)(F)F InChI=1S/C21H22F6N8O2S/c1-2-14-30-11-31-35(14)10-15(37)34-5-4-33(9-13(34)3-6-36)17-16(32-19(38-17)21(25,26)27)12-7-28-18(29-8-12)20(22,23)24/h7-8,11,13,36H,2-6,9-10H2,1H3 AZXNOMHWUBIVHT-UHFFFAOYSA-N 610437 US10053457, Example 33::2-(5-Ethyl-[1,2,4]triazol-1-yl)-1-{(R)-2-(2-hydroxy-ethyl)-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-ethanone C-X-C chemokine receptor type 3 Homo sapiens 652 US Patent 10.7270/Q2S46X2G aid1919603 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610437 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610437&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485736 483620602 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300220 CC(C)c1ncn(CC(=O)N2CCN(C[C@H]2CCO)c2sc(nc2-c2cnc(nc2)C(F)(F)F)C(F)(F)F)n1 InChI=1S/C22H24F6N8O2S/c1-12(2)17-31-11-35(33-17)10-15(38)36-5-4-34(9-14(36)3-6-37)18-16(32-20(39-18)22(26,27)28)13-7-29-19(30-8-13)21(23,24)25/h7-8,11-12,14,37H,3-6,9-10H2,1-2H3 WFZUDDFKDDQSCZ-UHFFFAOYSA-N 610438 US10053457, Example 34::1-{(R)-2-(2-Hydroxy-ethyl)-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-2-(3-isopropyl-[1,2,4]triazol-1-yl)-ethanone C-X-C chemokine receptor type 3 Homo sapiens 84.8 US Patent 10.7270/Q2S46X2G aid1919603 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610438 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610438&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485691 483620603 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300221 Cc1ncn(CC(=O)N2CCN(C[C@H]2CCO)c2sc(nc2-c2cnc(nc2)C(F)(F)F)C(F)(F)F)n1 InChI=1S/C20H20F6N8O2S/c1-11-29-10-33(31-11)9-14(36)34-4-3-32(8-13(34)2-5-35)16-15(30-18(37-16)20(24,25)26)12-6-27-17(28-7-12)19(21,22)23/h6-7,10,13,35H,2-5,8-9H2,1H3 FDZFVXKCJKOSRC-UHFFFAOYSA-N 610439 US10053457, Example 35::1-{(R)-2-(2-Hydroxy-ethyl)-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-2-(3-methyl-[1,2,4]triazol-1-yl)-ethanone C-X-C chemokine receptor type 3 Homo sapiens 102 US Patent 10.7270/Q2S46X2G aid1919603 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610439 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610439&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485701 483620604 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300222 Cc1ncnn1CC(=O)N1CCN(C[C@H]1CCO)c1sc(nc1-c1cnc(nc1)C(F)(F)F)C(F)(F)F InChI=1S/C20H20F6N8O2S/c1-11-29-10-30-34(11)9-14(36)33-4-3-32(8-13(33)2-5-35)16-15(31-18(37-16)20(24,25)26)12-6-27-17(28-7-12)19(21,22)23/h6-7,10,13,35H,2-5,8-9H2,1H3 YELKCXZWNROAEF-UHFFFAOYSA-N 610440 US10053457, Example 36::1-{(R)-2-(2-Hydroxy-ethyl)-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-2-(5-methyl-[1,2,4]triazol-1-yl)-ethanone C-X-C chemokine receptor type 3 Homo sapiens 451 US Patent 10.7270/Q2S46X2G aid1919603 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610440 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610440&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485734 483620605 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300223 COCc1ncn(CC(=O)N2CCN(C[C@H]2CCO)c2sc(nc2-c2cnc(nc2)C(F)(F)F)C(F)(F)F)n1 InChI=1S/C21H22F6N8O3S/c1-38-10-14-30-11-34(32-14)9-15(37)35-4-3-33(8-13(35)2-5-36)17-16(31-19(39-17)21(25,26)27)12-6-28-18(29-7-12)20(22,23)24/h6-7,11,13,36H,2-5,8-10H2,1H3 AFDXSDJIFGITNV-UHFFFAOYSA-N 610441 US10053457, Example 37::1-{(R)-2-(2-Hydroxy-ethyl)-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-2-(3-methoxymethyl-[1,2,4]triazol-1-yl)-ethanone C-X-C chemokine receptor type 3 Homo sapiens 393 US Patent 10.7270/Q2S46X2G aid1919603 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610441 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610441&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 135373703 483620606 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300224 OC[C@H]1CN(CCN1C(=O)Cn1cnc(n1)C(F)F)c1sc(nc1-c1cnc(nc1)C(F)(F)F)C(F)(F)F InChI=1S/C19H16F8N8O2S/c20-13(21)14-30-8-34(32-14)6-11(37)35-2-1-33(5-10(35)7-36)15-12(31-17(38-15)19(25,26)27)9-3-28-16(29-4-9)18(22,23)24/h3-4,8,10,13,36H,1-2,5-7H2 QPYREERGLRDOSN-UHFFFAOYSA-N 610442 US10053457, Example 38::2-(3-Difluoromethyl-[1,2,4]triazol-1-yl)-1-{(R)-2-hydroxymethyl-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-ethanone C-X-C chemokine receptor type 3 Homo sapiens 258 US Patent 10.7270/Q2S46X2G aid1919603 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610442 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610442&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485653 483620607 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300225 Cc1ccn(CC(=O)N2CCN(C[C@H]2CCO)c2sc(nc2-c2cnc(nc2)C(F)(F)F)C(F)(F)F)n1 InChI=1S/C21H21F6N7O2S/c1-12-2-4-33(31-12)11-15(36)34-6-5-32(10-14(34)3-7-35)17-16(30-19(37-17)21(25,26)27)13-8-28-18(29-9-13)20(22,23)24/h2,4,8-9,14,35H,3,5-7,10-11H2,1H3 NTFKMMZGMLEXET-UHFFFAOYSA-N 610443 US10053457, Example 39::1-{(R)-2-(2-Hydroxy-ethyl)-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-2-(3-methyl-pyrazol-1-yl)-ethanone C-X-C chemokine receptor type 3 Homo sapiens 46.3 US Patent 10.7270/Q2S46X2G aid1919603 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610443 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610443&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485718 483620608 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300226 CCc1ccn(CC(=O)N2CCN(C[C@H]2CCO)c2sc(nc2-c2cnc(nc2)C(F)(F)F)C(F)(F)F)n1 InChI=1S/C22H23F6N7O2S/c1-2-14-3-5-34(32-14)12-16(37)35-7-6-33(11-15(35)4-8-36)18-17(31-20(38-18)22(26,27)28)13-9-29-19(30-10-13)21(23,24)25/h3,5,9-10,15,36H,2,4,6-8,11-12H2,1H3 LEHFCHSREMRJMI-UHFFFAOYSA-N 610444 US10053457, Example 40::2-(3-Ethyl-pyrazol-1-yl)-1-{(R)-2-(2-hydroxy-ethyl)-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-ethanone C-X-C chemokine receptor type 3 Homo sapiens 32.7 US Patent 10.7270/Q2S46X2G aid1919603 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610444 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610444&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485628 483620609 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300227 OCC[C@@H]1CN(CCN1C(=O)Cn1ccc(n1)C1CC1)c1sc(nc1-c1cnc(nc1)C(F)(F)F)C(F)(F)F InChI=1S/C23H23F6N7O2S/c24-22(25,26)20-30-9-14(10-31-20)18-19(39-21(32-18)23(27,28)29)34-6-7-36(15(11-34)4-8-37)17(38)12-35-5-3-16(33-35)13-1-2-13/h3,5,9-10,13,15,37H,1-2,4,6-8,11-12H2 YTLUUFZLGZMZDK-UHFFFAOYSA-N 610445 US10053457, Example 41::2-(3-Cyclopropyl-pyrazol-1-yl)-1-{(R)-2-(2-hydroxy-ethyl)-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-ethanone C-X-C chemokine receptor type 3 Homo sapiens 30.2 US Patent 10.7270/Q2S46X2G aid1919603 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610445 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610445&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485700 483620610 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300228 Cc1ccn(CC(=O)N2CCN(C[C@H]2CO)c2sc(nc2-c2cnc(nc2)C(F)(F)F)C(F)(F)F)n1 InChI=1S/C20H19F6N7O2S/c1-11-2-3-32(30-11)9-14(35)33-5-4-31(8-13(33)10-34)16-15(29-18(36-16)20(24,25)26)12-6-27-17(28-7-12)19(21,22)23/h2-3,6-7,13,34H,4-5,8-10H2,1H3 GQQMDOGXIJRPDK-UHFFFAOYSA-N 610446 US10053457, Example 42::1-{(S)-2-Hydroxymethyl-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-2-(3-methyl-pyrazol-1-yl)-ethanone C-X-C chemokine receptor type 3 Homo sapiens 59.7 US Patent 10.7270/Q2S46X2G aid1919603 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610446 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610446&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485651 483620611 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300229 CCc1ccn(CC(=O)N2CCN(C[C@H]2CO)c2sc(nc2-c2cnc(nc2)C(F)(F)F)C(F)(F)F)n1 InChI=1S/C21H21F6N7O2S/c1-2-13-3-4-33(31-13)10-15(36)34-6-5-32(9-14(34)11-35)17-16(30-19(37-17)21(25,26)27)12-7-28-18(29-8-12)20(22,23)24/h3-4,7-8,14,35H,2,5-6,9-11H2,1H3 AYNOFJPXPRZEFF-UHFFFAOYSA-N 610448 US10053457, Example 43::2-(3-Ethyl-pyrazol-1-yl)-1-{(S)-2-hydroxymethyl-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-ethanone C-X-C chemokine receptor type 3 Homo sapiens 40.3 US Patent 10.7270/Q2S46X2G aid1919603 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610448 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610448&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485731 483620613 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 1300230 OC[C@@H]1CN(CCN1C(=O)Cn1ccc(n1)C1CC1)c1sc(nc1-c1cnc(nc1)C(F)(F)F)C(F)(F)F InChI=1S/C22H21F6N7O2S/c23-21(24,25)19-29-7-13(8-30-19)17-18(38-20(31-17)22(26,27)28)33-5-6-35(14(9-33)11-36)16(37)10-34-4-3-15(32-34)12-1-2-12/h3-4,7-8,12,14,36H,1-2,5-6,9-11H2 XLDNJQXRMYVGDR-UHFFFAOYSA-N 610449 US10053457, Example 44::2-(3-Cyclopropyl-pyrazol-1-yl)-1-{(S)-2-hydroxymethyl-4-[2-trifluoromethyl-4-(2-trifluoromethyl-pyrimidin-5-yl)-thiazol-5-yl]-piperazin-1-yl}-ethanone C-X-C chemokine receptor type 3 Homo sapiens 76.0 US Patent 10.7270/Q2S46X2G aid1919603 US10053457 Caroff, E; Meyer, E 8/21/2018 8/31/2023 Idorsia Pharmaceuticals http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=610449 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=610449&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 121485722 483620614 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL 8Y0N,8Y0H,8XYK,8XYI,8XXZ,8XXY,8K2X,8HNM,8HNL,8HNK C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5